Patent ID: 8975224
Filing Date: 2015-03-10
Classification: A61K,A61P,C07K

Abstract:
1. A method of treating an inflammatory condition by decreasing serum TNF-α levels in a human subject affected by the inflammatory condition comprising administering to the subject affected with the inflammatory condition a TNF-α level reducing amount of an oral formulation comprising a peptide consisting of the amino acid sequence selected from the group consisting of VKFNKPFVFLMIEQNTK (SEQ ID NO: 1), VKFAAAFVFLMIEQNTK (SEQ ID NO: 13), VKFNKPAAALMIEQNTK (SEQ ID NO: 14), VKFNKPFVFAAAEQNTK (SEQ ID NO: 15) and VKFNKPFVFLMIAAATK (SEQ ID NO: 16).